4//SEC Filing
Shah Jatin 4
Accession 0001209191-21-031481
CIK 0001503802other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 8:58 AM ET
Size
5.3 KB
Accession
0001209191-21-031481
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-05-07$8.60/sh+23,250$199,992→ 131,802 total
Footnotes (2)
- [F1]Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $8.5850 to $8.61, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 861 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2021.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 8:58 AM ET
- Size
- 5.3 KB